The News
Ablynx extends agreement with Wyeth
20/12/2007
GHENT, Belgium, 20 December 2007 - Ablynx [Euronext Brussels: ABLX], a pioneer in the discovery and development of Nanobodies®, a novel class of antibody-derived therapeutic proteins, announced today that its TNF-alpha partnership with Wyeth Pharmaceuticals has been extended for another year.
Wyeth and Ablynx are collaborating to discover and develop novel Nanobody®-based therapeutics against TNF-alpha. Wyeth has exclusive rights to develop and commercialise the anti-TNF-alpha Nanobodies® developed under the collaboration.
As part of the collaboration Ablynx receives research funding and would be entitled to future milestone payments and royalties upon commercialisation.
Dr. Edwin Moses, CEO and Chairman of Ablynx, commented:
"We are very pleased with the progress of our partnership with Wyeth, which has world class capabilities in the development and commercialisation of biologics. We look forward to continuing our collaboration for another year. This is an important partnership for Ablynx and we are delighted to continue our joint efforts to advance the TNF-alpha Nanobody®-based programme to the next stage."
Dr. Frank Walsh, Executive Vice President, Head of Discovery Research of Wyeth Pharmaceuticals said:
"We continue to be excited about the potential of Ablynx's Nanobody® technology as a platform for next-generation therapeutics targeted to TNF-alpha. We look forward to our ongoing collaboration with Ablynx with the goal of bringing new therapies to patients."
For more information, please contact:
College Hill Life Sciences - for UK/International media enquiries:
Sue Charles, Justine Lamond, Holly Griffiths
t: +44 (0)20 7457 2020
f: +44 (0)20 7866 7900
e: ablynx@collegehill.com <mailto:ablynx@collegehill.com>
Ablynx:
Dr. Edwin Moses
Chairman and CEO
t: +32 (0)9 262 00 07
m: +44 (0)7771 954 193 / +32 (0)473 39 50 68
e: edwin.moses@ablynx.com <mailto:edwin.moses@ablynx.com>
Eva-Lotta Allan
Chief Business Officer
t: +32 (0)9 262 00 75
m: +32 (0)475 78 36 21 / +44 (0)7990 570 900
e: eva-lotta.allan@ablynx.com <mailto:eva-lotta.allan@ablynx.com>
Complete version of the press release in ENGLISH <http://hugin.info/137912/R/1177598/234023.pdf>
2007
- 04/01/2007
-
08/01/2007
Movetis NV conclut un premier tour de financement de 49 millions d'euros
- 08/01/2007
- 09/01/2007
-
08/01/2007
UPEK is named CES Best of Innovations 2007 Design and Engineering Award Winner
-
16/01/2007
FOVEA Pharmaceuticals SA obtains Exclusive Worldwide Rights on RdCVF Protein Therapy
-
18/01/2007
CoreValve announces the appointment of Dolf Meewis as Vice President of International Sales
-
22/01/2007
INSIDE Launches High Performance MicroPass(R) L4-2G Contactless Platform
- 19/01/2007
-
15/01/2007
Varioptic and Creative Sensor Announce Liquid Lens Mass Production in China
-
24/01/2007
Addex starts Phase IIa Proof of Concept Study on ADX10061 for Smoking Cessation
- 31/01/2007
- 31/01/2007
- 31/01/2007
-
02/02/2007
Lenovo Mobile Selects Esmertec’s Jbed Software Solution to Power Major Platforms for Mobile Handsets
-
28/01/2007
UPEK Delivers First Biometric Security Software Solution for Windows Vista Operating System
- 02/02/2007
-
06/02/2007
Innate Pharma announces operating revenue of 8.4 million euros in 2006 and updates on its finances
-
06/02/2007
CPI Card Group Adopts INSIDE's Next-Generation MicroPass L4-2G Contactless Platform
- 08/02/2007
-
13/02/2007
Discover® Network certifies Inside Contactless chip for contactless payment cards & devices
- 14/02/2007
-
28/02/2007
IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvidem(R) in Melanoma
- 02/03/2007
-
08/03/2007
7TM Pharma advances the next first-in-class obesity compound into clinical development
- 08/03/2007
-
19/02/2007
Inside Contactless nominated for Performance AWARD Les Echos
-
08/03/2007
Streamezzo expands executive team with general manager for EMEA
- 13/03/2007
- 20/03/2007
- 26/03/2007
- 28/03/2007
- 29/03/2007
- 26/03/2007
-
03/04/2007
EmailVision : Forte progression du Résultat d'Exploitation au 2nd semestre 2006
- 03/04/2007
-
30/03/2007
Inside Extends Smart Card Alliance Involvement Within the Leadership Council
- 05/04/2007
- 10/04/2007
- 10/04/2007
- 17/04/2007
- 17/04/2007
- 08/03/2007
- 20/04/2007
-
20/04/2007
Addex reports positive results in Phase IIa clinical trial with ADX10059 in Migraine
-
26/04/2007
E-Mail Vision Forte croissance de l’activité au 1er trimestre 2007
-
26/04/2007
Innate Pharma S.A. announced two additional clinical trials for its IPH 1101 drug candidate
- 02/05/2007
- 03/05/2007
-
16/05/2007
ReVolt Technology and Phonak AG to Develop Rechargeable Zinc-air Battery Technology for Hearing Aids
- 16/05/2007
- 17/05/2007
-
30/05/2007
Esmertec Announces Robust Operational Performance in Q1 2007
- 05/06/2007
- 04/06/2007
- 01/06/2007
-
06/06/2007
Inside's Micropass reaches new milestone with 20 million units sold
- 07/06/2007
-
06/06/2007
MOVETIS Announces Start of A Phase IIa trial for M0002 in Ascites
- 07/06/2007
-
07/06/2007
NOXXON Pharma announces appointment of Dr. Walter Wenninger as Chairman of the Board
- 12/06/2007
-
23/05/2007
Streamezzo closes its second round of financing with investment from Qualcomm Ventures
- 10/06/2007
- 18/06/2007
-
18/06/2007
Ablynx identifies novel nanobodies® achieving second milestone in Procter & Gamble collaboration
-
21/06/2007
Innate Pharma has received approval for its phase II trial with IPH 1101 in HCV in France
- 21/06/2007
-
25/06/2007
Innate Pharma annonce un nouvel essai clinique avec IPH 2101 (NN 1975), le premier sous U.S ind
- 25/06/2007
- 27/06/2007
- 27/06/2007
-
29/06/2007
Frost & Sullivan Bestows its 2007 global contactless innovation & advancement award
-
02/07/2007
Ablynx announces interim results of first NANOBODY® Phase I study of ALX-0081 (anti-VWF)
- 06/07/2007
-
03/07/2007
Diatos Completes a Series D €9.4 Million Private Financing Round
-
10/07/2007
Sensitive Object and Tyco Electronics' Elo TouchSystems Business Sign License Agreement
- 09/05/2007
- 25/07/2007
-
25/07/2007
Addex Pharmaceuticals : Résultats Financiers du Premier Semestre 2007
-
30/05/2007
CTS International acquires Planet EV product line from Ericsson
- 05/07/2007
- 14/08/2007
- 06/08/2007
- 16/08/2007
- 24/07/2007
- 20/07/2007
-
24/07/2007
CoreValve named to Red Herring magazine’s ‘top 100’ North American private companies
-
22/08/2007
IBM Acquires WebDialogs to Expand Web Conferencing Capabilities in Industry-Leading Lotus Sametime
- 27/08/2007
- 27/08/2007
-
23/08/2007
Software and IT Executives Learn Growth and Exit Strategies at WFS' Fourth Annual London Conference
-
30/08/2007
Stentys appoints Hikmat Hojeibane as Chief Technology Officer
- 06/09/2007
- 07/09/2007
-
17/09/2007
DBV Technologies expands management team and moves to new facilities in Paris
-
18/09/2007
Inside chosen for world's first NFC-enabled M-payment rollout
-
19/09/2007
Sofinnova Partners Names Chika Yoshinaga Vice President, Asia
-
19/09/2007
Sofinnova Partners nomme le Dr Chika Yoshinaga Vice President, en charge de l’Asie
- 24/09/2007
- 24/09/2007
- 25/09/2007
-
25/09/2007
VoluBill raise 10.5 Million Euros to fund aggressive growth strategy
-
25/09/2007
VoluBill lève 10,5 Millions d’Euros pour financer une stratégie de croissance agressive
-
24/09/2007
First-in-man milestone reported for the Stentys bifurcated drug-eluting stent
-
25/09/2007
Purple Labs Raises .5 Million USD in Initial Round of Venture Capital Financing
-
29/09/2007
7TM Pharma hires experienced Director of Business Development and Medical Director
- 24/09/2007
-
01/10/2007
Noxxon Pharma appoints Dr. Joachim Kempeni as Chief Medical Officer
- 04/10/2007
- 10/10/2007
- 19/10/2007
-
22/10/2007
Diatos announces the successful completion of Phase I trial for DTS-201, a novel doxorubicin prodrug
- 23/10/2007
- 24/10/2007
- 23/10/2007
- 30/10/2007
-
30/10/2007
Kyocera WIRELESS and Inside Contactless join forces on NFC integration
- 30/10/2007
- 01/11/2007
-
05/11/2007
Inside Contactless empowers new generation NFC payment project with carrier Far EasTone in Taïwan
- 05/11/2007
- 06/11/2007
-
06/11/2007
ABLYNX RAISES €75 MILLION IN SUCCESSFUL IPO - Largest ever biotech IPO on Euronext Brussels
- 12/11/2007
- 23/10/2007
- 23/10/2007
- 07/11/2007
-
09/11/2007
INSIDE Contactless ranked in the Deloitte Technology Fast 50 list for South of France
-
09/11/2007
Noxxon Pharma announces research & development alliance with Roche regarding inflammatory diseases.
- 13/11/2007
- 13/11/2007
-
13/11/2007
DBV Technologies stengthens board of Directors and Scientific Advisory Board
- 13/11/2007
- 14/11/2007
- 15/11/2007
- 05/11/2007
- 12/11/2007
-
16/11/2007
Esmertec reduces debts and increases equity by early conversion of outstanding convertible bonds
-
03/12/2007
Addex and Merck & Co. Collaborate to Develop Drugs for Parkinson’s Disease
- 04/12/2007
-
04/12/2007
Preglem SA announces CHF 36 million Series B funding and new licencing agreement with HRA Pharma
-
27/11/2007
FOVEA Pharmaceuticals Enter Into a Research Collaboration in Ophthalmology With GENZYME Corporation
- 27/11/2007
-
11/12/2007
Nokia Growth Partners leads Series C investment round in INSIDE Contactless
- 12/12/2007
-
13/12/2007
Ascendis Pharma A/S Completes €17.6 Million Series-A Financing
-
16/12/2007
Movistar selects Esmertec’s USSD platform for Latin American operations
-
13/12/2007
Mobile Digital Media Named Exclusive Retail Publisher and Distributor for Atkins™ Carb Counter
-
17/12/2007
Ablynx reports positive phase I results for its anti-thrombotic nanobody®, ALX-0081
-
20/12/2007
Ablynx extends agreement with Wyeth
-
05/12/2007
SFR adopte la plate-forme de Streamezzo pour optimiser son nouveau portail rich media
-
05/12/2007
SFR adopts Streamezzo's software platform to power new rich media portal
-
10/12/2007
Streamezzo names Alex Middleton General Manager for Americas
- 27/12/2007
- 10/04/2007
